These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37479759)

  • 41. An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma.
    Chen Y; Lin QX; Xu YT; Qian FJ; Lin CJ; Zhao WY; Huang JR; Tian L; Gu DN
    Front Oncol; 2023; 13():1158605. PubMed ID: 37182175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma.
    Chen Y; Huang M; Zhu J; Xu L; Cheng W; Lu X; Yan F
    Front Pharmacol; 2022; 13():857060. PubMed ID: 35496321
    [No Abstract]   [Full Text] [Related]  

  • 43. Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma.
    Wang Z; Chen X; Zhang J; Chen X; Peng J; Huang W
    Front Immunol; 2023; 14():1204338. PubMed ID: 37680641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
    Chen S; Zhao E
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
    Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
    Front Genet; 2022; 13():907331. PubMed ID: 35938001
    [No Abstract]   [Full Text] [Related]  

  • 46. Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis.
    Huang C; Zhang C; Sheng J; Wang D; Zhao Y; Qian L; Xie L; Meng Z
    Front Genet; 2021; 12():717319. PubMed ID: 34899826
    [No Abstract]   [Full Text] [Related]  

  • 47. Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma.
    Zhu XR; Zhu JQ; Chen YF; Liu YY; Lu JJ; Sun J; Peng SQ; Chen MB; Du YP
    Front Oncol; 2022; 12():972744. PubMed ID: 35982956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction and validation of a prognostic marker and risk model for HCC ultrasound therapy combined with WGCNA identification.
    Bi Y; Jing Y; Guo L
    Front Genet; 2022; 13():1017551. PubMed ID: 36263426
    [No Abstract]   [Full Text] [Related]  

  • 49. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
    Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X
    Front Immunol; 2023; 14():1218661. PubMed ID: 37662906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma.
    Zheng C; Peng Y; Wang H; Wang Y; Liu L; Zhao Q
    Pharmgenomics Pers Med; 2023; 16():39-58. PubMed ID: 36726530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
    Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
    Front Immunol; 2022; 13():950001. PubMed ID: 36091041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases.
    Ma Q; Hui Y; Huang BR; Yang BF; Li JX; Fan TT; Gao XC; Ma DY; Chen WF; Pei ZX
    Transl Cancer Res; 2023 Jan; 12(1):46-64. PubMed ID: 36760376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
    Wang T; Zhou Z; Wang X; You L; Li W; Zheng C; Zhang J; Wang L; Kong X; Gao Y; Sun X
    Front Genet; 2022; 13():929035. PubMed ID: 36081998
    [No Abstract]   [Full Text] [Related]  

  • 54. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
    Chen J; Chen X; Li T; Wang L; Lin G
    Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.
    Chen X; Hu G; Xiong L; Xu Q
    Pathol Oncol Res; 2022; 28():1610558. PubMed ID: 36213162
    [No Abstract]   [Full Text] [Related]  

  • 56. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
    Liu GM; Zeng HD; Zhang CY; Xu JW
    Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
    Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W
    Front Oncol; 2021; 11():629327. PubMed ID: 33718205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients.
    Lv W; Yao Q
    Dis Markers; 2022; 2022():9428660. PubMed ID: 35069936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma.
    Wang Q; Wang B; Ma X; Zhuang H; Xie Z; Tang C; Tan W; Yang L; Shang C; Chen Y
    J Hepatocell Carcinoma; 2023; 10():1-16. PubMed ID: 36647389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A stemness-based eleven-gene signature correlates with the clinical outcome of hepatocellular carcinoma.
    Hong L; Zhou Y; Xie X; Wu W; Shi C; Lin H; Shi Z
    BMC Cancer; 2021 Jun; 21(1):716. PubMed ID: 34147074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.